MOTS-C is generally well-tolerated in the clinical context in which it is prescribed. A medical assessment is required before MOTS-C is prescribed.
MOTS-C is not for use in:
Additional precautions for specific populations:
MOTS-C can be combined with Direct Meds' weight management suite. When used alongside GLP-1 medications (semaglutide and tirzepatide), the interaction is synergistic: GLP-1s work primarily through appetite suppression and slowing digestion, while MOTS-C works on fat oxidation and muscle glucose uptake. One of the biggest risks of GLP-1 therapy is muscle loss (sarcopenia), and MOTS-C helps protect muscle mass by keeping it metabolically active. Always review your full medication list with your provider before starting.
A medical assessment is required before MOTS-C is prescribed. Your provider will review your health history, current medications, and indication to confirm MOTS-C is appropriate for you.